CKR1C_CONRO
ID CKR1C_CONRO Reviewed; 96 AA.
AC P0DKZ1;
DT 03-APR-2013, integrated into UniProtKB/Swiss-Prot.
DT 03-APR-2013, sequence version 1.
DT 03-AUG-2022, entry version 21.
DE RecName: Full=Conantokin Rl-C {ECO:0000305};
DE Short=Con Rl-C {ECO:0000305};
DE Short=ConRl-C {ECO:0000303|PubMed:22594498};
DE Flags: Precursor; Fragment;
OS Conus rolani (Cone snail).
OC Eukaryota; Metazoa; Spiralia; Lophotrochozoa; Mollusca; Gastropoda;
OC Caenogastropoda; Neogastropoda; Conoidea; Conidae; Conus; Asprella.
OX NCBI_TaxID=745791;
RN [1]
RP NUCLEOTIDE SEQUENCE [GENOMIC DNA], SYNTHESIS OF 79-96, FUNCTION,
RP GAMMA-CARBOXYGLUTAMATION AT GLU-81; GLU-82; GLU-85; GLU-89 AND GLU-93, AND
RP AMIDATION AT ASN-96.
RX PubMed=22594498; DOI=10.1021/bi300055n;
RA Gowd K.H., Han T.S., Twede V., Gajewiak J., Smith M.D., Watkins M.,
RA Platt R.J., Toledo G., White H.S., Olivera B.M., Bulaj G.;
RT "Conantokins derived from the Asprella clade impart conRl-B, an N-methyl d-
RT aspartate receptor antagonist with a unique selectivity profile for NR2B
RT subunits.";
RL Biochemistry 51:4685-4692(2012).
CC -!- FUNCTION: Conantokins inhibit N-methyl-D-aspartate (NMDA) receptors.
CC This toxin has antagonist activity on NR2B/GRIN2B (IC(50)=1.4 uM) and
CC NR2A/GRIN2A (IC(50)=2.9 uM) subunits, when tested on rat receptors.
CC {ECO:0000269|PubMed:22594498}.
CC -!- COFACTOR:
CC Name=Ca(2+); Xref=ChEBI:CHEBI:29108;
CC Evidence={ECO:0000250|UniProtKB:P07231};
CC Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC Evidence={ECO:0000250|UniProtKB:P07231};
CC Note=Divalent cations stabilize the toxin the in alpha-helix
CC conformation. {ECO:0000250|UniProtKB:P07231};
CC -!- SUBCELLULAR LOCATION: Secreted {ECO:0000305|PubMed:22594498}.
CC -!- TISSUE SPECIFICITY: Expressed by the venom duct.
CC {ECO:0000305|PubMed:22594498}.
CC -!- MISCELLANEOUS: The mature peptide does not contain cysteine residue.
CC {ECO:0000305}.
CC -!- MISCELLANEOUS: Has no antagonist activity on NR2C/GRIN2C, and
CC NR2D/GRIN2D subunits. {ECO:0000305|PubMed:22594498}.
CC -!- SIMILARITY: Belongs to the conotoxin B superfamily. {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR AlphaFoldDB; P0DKZ1; -.
DR ConoServer; 5850; Conantokin-Rl3 precursor.
DR GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR GO; GO:0035792; C:host cell postsynaptic membrane; IEA:UniProtKB-KW.
DR GO; GO:0099106; F:ion channel regulator activity; IEA:UniProtKB-KW.
DR GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR GO; GO:0090729; F:toxin activity; IEA:UniProtKB-KW.
DR InterPro; IPR005918; Conantokin_CS.
DR PROSITE; PS60025; CONANTOKIN; 1.
PE 1: Evidence at protein level;
KW Amidation; Calcium; Gamma-carboxyglutamic acid;
KW Ion channel impairing toxin; Ionotropic glutamate receptor inhibitor;
KW Magnesium; Metal-binding; Neurotoxin; Postsynaptic neurotoxin; Secreted;
KW Signal; Toxin.
FT SIGNAL 1..21
FT /evidence="ECO:0000255"
FT PROPEP 22..78
FT /evidence="ECO:0000305|PubMed:22594498"
FT /id="PRO_0000421896"
FT PEPTIDE 79..96
FT /note="Conantokin Rl-C"
FT /evidence="ECO:0000305|PubMed:22594498"
FT /id="PRO_0000421897"
FT REGION 36..85
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT BINDING 81
FT /ligand="a divalent metal cation"
FT /ligand_id="ChEBI:CHEBI:60240"
FT /note="via 4-carboxyglutamate"
FT /evidence="ECO:0000250|UniProtKB:P07231"
FT BINDING 85
FT /ligand="a divalent metal cation"
FT /ligand_id="ChEBI:CHEBI:60240"
FT /note="via 4-carboxyglutamate"
FT /evidence="ECO:0000250|UniProtKB:P07231"
FT BINDING 89
FT /ligand="a divalent metal cation"
FT /ligand_id="ChEBI:CHEBI:60240"
FT /note="via 4-carboxyglutamate"
FT /evidence="ECO:0000250|UniProtKB:P07231"
FT BINDING 93
FT /ligand="a divalent metal cation"
FT /ligand_id="ChEBI:CHEBI:60240"
FT /note="via 4-carboxyglutamate"
FT /evidence="ECO:0000250|UniProtKB:P07231"
FT MOD_RES 81
FT /note="4-carboxyglutamate"
FT /evidence="ECO:0000250|UniProtKB:P07231,
FT ECO:0000305|PubMed:22594498"
FT MOD_RES 82
FT /note="4-carboxyglutamate"
FT /evidence="ECO:0000250|UniProtKB:P07231,
FT ECO:0000305|PubMed:22594498"
FT MOD_RES 85
FT /note="4-carboxyglutamate"
FT /evidence="ECO:0000250|UniProtKB:P07231,
FT ECO:0000305|PubMed:22594498"
FT MOD_RES 89
FT /note="4-carboxyglutamate"
FT /evidence="ECO:0000250|UniProtKB:P07231,
FT ECO:0000305|PubMed:22594498"
FT MOD_RES 93
FT /note="4-carboxyglutamate"
FT /evidence="ECO:0000250|UniProtKB:P07231,
FT ECO:0000305|PubMed:22594498"
FT MOD_RES 96
FT /note="Asparagine amide"
FT /evidence="ECO:0000250|UniProtKB:P07231,
FT ECO:0000305|PubMed:22594498"
FT NON_TER 96
SQ SEQUENCE 96 AA; 10864 MW; 37B5511265166809 CRC64;
MQLYTYLYLL VPLVTFHLIL GTGTLDHGDA LTERRSADAT ALKPEPVLLQ KSSARSTDDN
GKDTQMKRIF KKRRNKARGE EELSENAVEF ARELAN